The Indian Homoeopathic Medical Association (IHMA) has demanded to the government to ban the over-the-counter (OTC) sale of the swine flu drug Influenzinum200, manufactured by Dr Reckeweg, a German pharmaceutical company.
The association has written to Central Council of Homoeopathy (CCH), Central Council for Research in Homoeopathy (CCRH), Central Ayush department, Maharashtra FDA and all the state drug control authorities to immediately stop the OTC sale of Influenzinum200.
According to sources, the drug is being promoted by pharmaceutical lobbies on whatsapp and facebook as a preventive medicine for swine flu and it is being sold without the prescription of registered homoeopathic practitioners.
Dr.Pawan S Chandak, national vice president, IHMA informed that Influenzinum was not included in Homoeopathic Pharmacopoeia of India, so it cannot be sold directly without the prescription. It is prepared from virus, yet it lacks efficacy with no scientific clinical research data available. Therefore, it is not proved, so it is dangerous to use it without the prescription of registered homoeopathic practitioners.
The drug is not registered in Homoeopathic Pharmacopoeia of India and in homoeopathy preventive medicine is prescribed only on the basis of ‘Genus Epidemicus’. Even as per Materia Medica no clinical picture of swine flu matches with Influenzinum.
Further he opined that CCRH suggested Arsenicum album 30 as a preventive medicine for swine flu and it was better to use that remedy [Source]
Be the first to comment